Gene · 5236
Papers2,310
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,310
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Congenital disorders of glycosylation: narration of a story through its patents. | Orphanet J Rare Dis | 2023 | 37644541 | PubTator, text mining | PubMed |
| Four types of adenine-related RNA modification writers -mediated molecular subtypes contribute to predicting clinical outcomes and treatment options in bladder cancer. | Front Immunol | 2023 | 37638051 | PubTator, text mining | PubMed |
| Identification and validation of potential hypoxia-related genes associated with coronary artery disease. | Front Physiol | 2023 | 37637145 | PubTator, text mining | PubMed |
| Tripartite Motif-Containing Protein 32 (TRIM32): What Does It Do for Skeletal Muscle? | Cells | 2023 | 37626915 | PubTator, text mining | PubMed |
| Primary non leukemic myeloid sarcoma of the ureteral wall: a case report of a rare disease. | J Surg Case Rep | 2023 | 37614469 | PubTator, text mining | PubMed |
| FGF1 supports glycolytic metabolism through the estrogen receptor in endocrine-resistant and obesity-associated breast cancer. | Breast Cancer Res | 2023 | 37608351 | PubTator, text mining | PubMed |
| Identification of genotype-biochemical phenotype correlations associated with fructose 1,6-bisphosphatase deficiency. | Commun Biol | 2023 | 37507476 | PubTator, text mining | PubMed |
| Vagus nerve inflammation contributes to dysautonomia in COVID-19. | Acta Neuropathol | 2023 | 37452829 | PubTator, text mining | PubMed |
| Pembrolizumab-Induced Fatal Myasthenia, Myocarditis, and Myositis in a Patient with Metastatic Melanoma: Autopsy, Histological, and Immunohistochemical Findings-A Case Report and Literature Review. | Int J Mol Sci | 2023 | 37446095 | PubTator, text mining | PubMed |
| Analysis of the Peritumoral Tissue Unveils Cellular Changes Associated with a High Risk of Recurrence. | Cancers (Basel) | 2023 | 37444560 | PubTator, text mining | PubMed |
| Isotopic Tracing of Nucleotide Sugar Metabolism in Human Pluripotent Stem Cells. | Cells | 2023 | 37443799 | PubTator, text mining | PubMed |
| MTA1, a Novel ATP Synthase Complex Modulator, Enhances Colon Cancer Liver Metastasis by Driving Mitochondrial Metabolism Reprogramming. | Adv Sci (Weinh) | 2023 | 37442756 | PubTator, text mining | PubMed |
| One-year longitudinal study of the stratum corneum proteome of retinol and all-trans-retinoic acid treated human skin: an orchestrated molecular event. | Sci Rep | 2023 | 37433822 | PubTator, text mining | PubMed |
| Hyperinsulinemic Hypoglycemia and Growth Hormone Deficiency Secondary to 20p11 Deletion. | Case Rep Endocrinol | 2023 | 37404330 | PubTator, text mining | PubMed |
| Proteomic Comparison of Paraspinal Muscle Imbalance Between Idiopathic Scoliosis and Congenital Scoliosis. | Neurospine | 2023 | 37401090 | PubTator, text mining | PubMed |
| Lymphocyte-to-monocyte ratio as a prognostic and potential tumor microenvironment indicator in advanced soft tissue sarcoma treated with first-line doxorubicin therapy. | Sci Rep | 2023 | 37400504 | PubTator, text mining | PubMed |
| Validation of protein biological markers of lamb meat quality characteristics based on the different muscle types. | Food Chem | 2023 | 37392625 | PubTator, text mining | PubMed |
| Myeloid sarcoma incidentally found in lymph nodes dissected for advanced gastric cancer. | J Clin Exp Hematop | 2023 | 37380469 | PubTator, text mining | PubMed |
| Follicular Lymphoma Microenvironment Traits Associated with Event-Free Survival. | Int J Mol Sci | 2023 | 37373066 | PubTator, text mining | PubMed |
| Loss of PRDX6 Aborts Proliferative and Migratory Signaling in Hepatocarcinoma Cell Lines. | Antioxidants (Basel) | 2023 | 37371884 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5236/papers?page=8